|
Press Releases |
|
|
|
Monday, August 22, 2022 |
|
Sirnaomics Becoming A Constituent of Hang Seng Family of Indexes |
Sirnaomics Ltd. (the "Company" or "Sirnaomics", stock code: 2257.HK), a leading biopharmaceutical company in discovery and development of RNAi therapeutics, announced that the Company has been selected as a constituent stock of eight index series including Hang Seng Composite Index ("HSCI") more info >> |
|
Friday, August 19, 2022 |
|
Sirnaomics Doses the First Patient in Phase I/II Clinical Study of RNAi Therapeutic STP705 for Treatment of Facial Squamous Cell Skin Cancer In Situ |
Sirnaomics Ltd. (the "Company" or "Sirnaomics", stock code: 2257.HK), a leading biopharmaceutical company in discovery and development of RNAi therapeutics, announced today that the Company has dosed the first patient in a Phase I/II clinical study of STP705 more info >> |
|
Tuesday, August 16, 2022 |
|
Sirnaomics Develops Peptide Docking Vehicle (PDoV(TM)) Designed for an Enhanced GalNAc Delivery Platform for Novel siRNA Therapeutics |
Sirnaomics Ltd. (the "Company" or "Sirnaomics", stock code: 2257.HK), a leading biopharmaceutical company in discovery and development of RNAi therapeutics, announced today that the Company has developed a Peptide Docking Vehicle (PDoV(TM)) to achieve a peptide-enhanced GalNAc platform for siRNA drug delivery. more info >> |
|
Tuesday, July 26, 2022 |
|
Sirnaomics Receives IND Clearance from the Taiwan Ministry of Health and Welfare for Phase I Clinical Study of RNAi Therapeutic STP705 for Liver Cancer Treatment |
Sirnaomics Ltd. (the "Company" or "Sirnaomics", stock code: 2257.HK), a leading biopharmaceutical company in discovery and development of RNAi therapeutics more info >> |
|
Tuesday, June 21, 2022 |
|
Sirnaomics to Present the Latest Developments of Dual-Targeted RNAi Therapeutics based on its Proprietary GalAhead(TM) Program at the 4th Annual RNA Therapeutic: From Concept to Clinic Symposium |
Sirnaomics Ltd. (the "Company" or "Sirnaomics", stock code: 2257.HK), a leading biopharmaceutical company in discovery and development of RNAi therapeutics, announced that the Company's Chief Technology Officer more info >> |
|
Thursday, June 16, 2022 |
|
Sirnaomics Announces Publication of STP705 Clinical Study Results for Treatment of isSCC in the Peer-Reviewed Journal of Drugs in Dermatology |
Sirnaomics Ltd. ("Sirnaomics", stock code: 2257.HK), a leading biopharmaceutical company in discovery and development of RNAi therapeutics, announced the peer-reviewed publication of Phase IIa clinical study results of its lead therapeutic candidate, STP705, for the treatment of skin cancer, in the May 2022 issue of the Journal of Drugs in Dermatology (the "JDD"). more info >> |
|
Monday, May 30, 2022 |
|
Sirnaomics Launches Phase I Clinical Trial of RNAi Therapeutic STP705 in Adults Undergoing Abdominoplasty for Medical Cosmetology Treatment |
Sirnaomics Ltd. (the "Company" or "Sirnaomics", stock code: 2257.HK), a leading biopharmaceutical company in discovery and development of RNAi therapeutics, announced today the launch of a Phase I clinical trial of the Company's siRNA (small interfering RNA) drug candidate, STP705, in adults undergoing abdominoplasty for submental fat reduction. more info >> |
|
Friday, May 20, 2022 |
|
Sirnaomics will present clinical study results and development strategy for Cancer RNA Therapeutics at the 2022 Pre-ASCO China Summit |
Sirnaomics Ltd. (the "Company" or "Sirnaomics", stock code: 2257.HK), a leading biopharmaceutical company in discovery and development of RNAi therapeutics, announced today that the Company's Executive Director and Chief Medical Officer, Dr. Michael Molyneaux more info >> |
|
Wednesday, May 11, 2022 |
|
Sirnaomics to Present Latest Developments on its GalNAc-Based Liver-Targeting Platforms and GalAhead(TM) Programs at the TIDES USA 2022 |
Sirnaomics Ltd. ("Sirnaomics", stock code: 2257.HK), a leading biopharmaceutical company in discovery and development of RNAi therapeutics more info >> |
|
Thursday, December 30, 2021 |
|
Sirnaomics Ltd., RNA Therapeutics Biopharmaceutical Company with Presence in China and US, Lists on Main Board of SEHK |
Sirnaomics Ltd. ("Sirnaomics" or "Company", together with its subsidiaries, the "Group", stock code: 2257.HK), the RNA therapeutics biopharmaceutical company with strong presence in both China and the U.S., more info >> |
|
|
|
|
|
|
|
|
|
Latest Press Releases |
|
Mitsubishi Heavy Industries Continues Order Intake, Revenue, and Profit Growth in Strong First Half, Raises Full-Year Order Intake Guidance
Nov 5, 2024 14:37 JST
|
|
|
Interroyal Engineering PCL (SET: IROYAL) Posts Strong Showing on First Trading Day
Nov 5, 2024 13:00 HKT/SGT
|
|
|
Eisai's Corporate Venture Capital Subsidiary, Eisai Innovation, Inc., Selected for AMED's 'Strengthening Program for Pharmaceutical Startup Ecosystem"
Nov 5, 2024 11:35 JST
|
|
|
APTEXPO 2024 To Empower Asia Pacific's Fashion And Supply Chain Decision Makers For The Future
Nov 5, 2024 09:00 HKT/SGT
|
|
|
Source Intelligence Evolves With C-Map: Delivering Next-Generation SaaS Platform for Compliance & Sustainability
Nov 5, 2024 05:00 HKT/SGT
|
|
|
With interest rate cuts taking effect, CWT hopes to take advantage of the favorable macro trend
Nov 5, 2024 01:01 HKT/SGT
|
|
|
LQR House Inc. Reports 424.58% Year-Over-Year Revenue Growth in October 2024 Compared to October 2023
Nov 4, 2024 22:00 HKT/SGT
|
|
|
HEROWORKS Embarks on Global Expansion with Hotel Revenue Management System
Nov 4, 2024 17:00 HKT/SGT
|
|
|
JBM Healthcare Limited Issues Positive Profit Alert
Nov 4, 2024 15:00 HKT/SGT
|
|
|
Will New Gonow Recreational Vehicles Make It the Next Thor Industries?
Nov 4, 2024 14:52 HKT/SGT
|
|
|
Asahi Kasei and Honda Sign Shareholders' Agreement to Convert Existing Asahi Kasei Subsidiary into Joint Venture for Production of Lithium-ion Battery Separators in Canada
Nov 4, 2024 14:12 JST
|
|
|
GTJAI was selected into the first batch of qualified securities companies for the 'Cross-boundary Wealth Management Pilot Scheme'
Nov 4, 2024 10:58 HKT/SGT
|
|
|
Joby Aviation and Toyota Accelerate Efforts to Realize Air Mobility
Nov 4, 2024 9:36 JST
|
|
|
Autumn Lighting Fair, Outdoor and Tech Light Expo and Eco Expo Asia draw some 60,000 buyers
Nov 3, 2024 12:46 HKT/SGT
|
|
|
Announcement of the Launch of Toho Entertainment Asia Operations in Singapore
Nov 2, 2024 06:00 HKT/SGT
|
|
|
|
More Press release >> |
|
|
|
|
|
|
|